Trends in Anti-Influenza Drug Prescription and Adverse Drug Reaction Reporting After the Lifting of Oseltamivir Prescribing Restrictions in Pediatric Outpatients: An Ecological Study Using the MDV Analyzer® And the Japanese Adverse Drug Event Report Database

• Autori principali: Misaki Tokunaga (Autore), Daisuke Kikuchi (Autore), Aoi Noda (Autore), Sachiko Oikawa (Autore), Makoto Shiozawa (Autore), Hiroaki Hino (Autore), Ryosuke Miura (Autore), Kensuke Usui (Autore), Taku Obara (Autore), Kouji Okada (Autore)
• Natura: Libro
• Pubblicazione: Adis, Springer Healthcare, 2024-01-01T00:00:00Z.
• Soggetti: article
• Accesso online: Connect to this object online.

Abstract Background Abnormal behavior after oseltamivir administration has been reported in the media; in 2007, the package insert for oseltamivir phosphate was revised to restrict its administration to individuals aged over 10 years. However, in 2018, the age limitation specified in the package ins...